These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3895277)
21. Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia. Boyle PJ; Cryer PE Am J Physiol; 1991 Mar; 260(3 Pt 1):E395-402. PubMed ID: 2003593 [TBL] [Abstract][Full Text] [Related]
22. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia. Sotsky MJ; Shilo S; Shamoon H J Clin Endocrinol Metab; 1989 Jan; 68(1):9-16. PubMed ID: 2642489 [TBL] [Abstract][Full Text] [Related]
23. Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. Santiago JV; Clarke WL; Shah SD; Cryer PE J Clin Endocrinol Metab; 1980 Oct; 51(4):877-83. PubMed ID: 6999000 [No Abstract] [Full Text] [Related]
24. Responses of catecholamines and other counterregulatory hormones to insulin-induced hypoglycemia in totally pancreatectomized patients. Horie H; Matsuyama T; Namba M; Itoh H; Nonaka K; Tarui S; Yamatodani A; Wada H J Clin Endocrinol Metab; 1984 Dec; 59(6):1193-6. PubMed ID: 6386840 [TBL] [Abstract][Full Text] [Related]
25. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes. Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785 [TBL] [Abstract][Full Text] [Related]
26. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. Davis SN; Shavers C; Davis B; Costa F J Clin Invest; 1997 Jul; 100(2):429-38. PubMed ID: 9218521 [TBL] [Abstract][Full Text] [Related]
27. Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy. Horie H; Hanafusa T; Matsuyama T; Namba M; Nonaka K; Tarui S; Yamatodani A; Wada H Horm Metab Res; 1984 Aug; 16(8):398-401. PubMed ID: 6381272 [TBL] [Abstract][Full Text] [Related]
28. The influence of short term submaximal work on the plasma concentrations of catecholamines, pancreatic glucagon and growth hormone in man. Nilsson KO; Heding LG; Hökfelt B Acta Endocrinol (Copenh); 1975 Jun; 79(2):286-94. PubMed ID: 1173488 [TBL] [Abstract][Full Text] [Related]
29. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039 [TBL] [Abstract][Full Text] [Related]
30. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Vea H; Jorde R; Sager G; Vaaler S; Sundsfjord J Diabetologia; 1992 Oct; 35(10):958-61. PubMed ID: 1451953 [TBL] [Abstract][Full Text] [Related]
31. Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. McGregor VP; Banarer S; Cryer PE Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E770-7. PubMed ID: 11882496 [TBL] [Abstract][Full Text] [Related]
32. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus. Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892 [TBL] [Abstract][Full Text] [Related]
33. Demonstration of a dawn phenomenon in normal human volunteers. Bolli GB; De Feo P; De Cosmo S; Perriello G; Ventura MM; Calcinaro F; Lolli C; Campbell P; Brunetti P; Gerich JE Diabetes; 1984 Dec; 33(12):1150-3. PubMed ID: 6389230 [TBL] [Abstract][Full Text] [Related]
34. Exaggerated plasma catecholamines and cortisol responses to hypoglycemic stress in essential hypertension. Paolisso G; Buoninconti R; Sgambato S; Torella R; Varricchio M; D'Onofrio F Diabetes Care; 1988 Mar; 11(3):300-2. PubMed ID: 3416692 [No Abstract] [Full Text] [Related]
35. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man. Schade DS; Eaton RP Diabetes; 1979 Jan; 28(1):5-10. PubMed ID: 759250 [No Abstract] [Full Text] [Related]
36. The metabolic and hormonal response to glucagon. Part 1. Normal subjects. Goodwin PM; Capildeo R; Harrop JS; Marks V; Rose FC J Neurol Sci; 1976 Mar; 27(3):373-80. PubMed ID: 1262901 [TBL] [Abstract][Full Text] [Related]
37. Selective counterregulatory hormone responses after oral glucose in man. Kleinbaum J; Shamoon H J Clin Endocrinol Metab; 1982 Oct; 55(4):787-90. PubMed ID: 7107822 [TBL] [Abstract][Full Text] [Related]
38. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon. Staten MA; Matthews DE; Cryer PE; Bier DM Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829 [TBL] [Abstract][Full Text] [Related]